title: Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
authors.affiliation: Department of Cardiology, Vall d'Hebron Universty Hospital and Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Antonia
authors.initials: A
authors.lastname: Sambola
authors.forename: David
authors.initials: D
authors.lastname: García-Dorado
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D003324:Coronary Artery Disease / Q000628:therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000295:instrumentation*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D015607:Stents; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; D014859:Warfarin; D001241:Aspirin